Recompensas para aumentar la donación de riñón vivo: el estado del arte

© © 2018 Sociedad Española de Nefrología. Published by Elsevier España, S.L.U. This is an open access article under the CCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)The incidence of end-stage renal disease (ESRD) is increasing worldwide. When compared to dialysis, renal transplantation (RT) leads to a survival advantage and to an improvement in quality of life in most ESRD patients. Additionally, from a societal perspective, RT is the most cost-effective modality of renal replacement therapy (RRT) for eligible patients. In the last decades, RT has prolonged and improved the lives of hundreds of thousands of patients worldwide. Nevertheless, although the prevalence of ESRD is increasing in most countries, transplantation rates have not kept pace. In 2016, there were nearly 2000 patients waiting for RT in Portugal and only 500 kidney transplants were performed, illustrating the clear discrepancy between the number of transplants and the number of patients awaiting for transplantation.